Journal article · 2026

Next-generation KRAS G12C inhibitor improves survival in lung cancer

Ulrike Harjes

Nature Medicine · Published 10 November 2026 · DOI 10.1038/d41591-026-00057-9

View at the publisherCite this paper

In brief

“Next-generation KRAS G12C inhibitor improves survival in lung cancer” is a 2026 journal article by Ulrike Harjes, published in Nature Medicine. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Harjes, U. (2026). Next-generation KRAS G12C inhibitor improves survival in lung cancer. Nature Medicine. https://doi.org/10.1038/d41591-026-00057-9

MLA 9

Harjes, Ulrike. “Next-generation KRAS G12C inhibitor improves survival in lung cancer.” Nature Medicine, 2026. https://doi.org/10.1038/d41591-026-00057-9.

Chicago

Harjes, Ulrike. 2026. “Next-generation KRAS G12C inhibitor improves survival in lung cancer.” Nature Medicine. https://doi.org/10.1038/d41591-026-00057-9.

Harvard

Harjes, U. (2026) ‘Next-generation KRAS G12C inhibitor improves survival in lung cancer’, Nature Medicine. doi:10.1038/d41591-026-00057-9.

IEEE

U. Harjes, “Next-generation KRAS G12C inhibitor improves survival in lung cancer,” Nature Medicine, 2026, doi: 10.1038/d41591-026-00057-9.

BibTeX

@article{harjes2026next,
  title     = {{Next-generation KRAS G12C inhibitor improves survival in lung cancer}},
  author    = {Harjes, Ulrike},
  journal   = {Nature Medicine},
  year      = {2026},
  doi       = {10.1038/d41591-026-00057-9},
  url       = {https://doi.org/10.1038/d41591-026-00057-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations

  • KRAS G12C inhibitors
  • divarasib
  • sotorasib
  • adagrasib
  • non-small cell lung cancer
  • progression-free survival
  • targeted therapy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Harjes, U. (2026). Next-generation KRAS G12C inhibitor improves survival in lung cancer. Nature Medicine. https://doi.org/10.1038/d41591-026-00057-9

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ulrike Harjes.

What is the DOI of this paper?

10.1038/d41591-026-00057-9, permanently at https://doi.org/10.1038/d41591-026-00057-9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.